Symbion Health says a proposal by Sigma and a private equity consortium to acquire Symbion's pharmacy services lacks sufficient information. Symbion says need more info from Sigma.

Sigma Pharmaceuticals hopes to finalise a proposal to buy Symbion Health's consumer and pharmacy business by Monday, despite the target company announcing yesterday it wasn't taking the indicative ...

Sigma Pharmaceuticals is considering its options after losing the bidding for Symbion Health's consumer and pharmacy services divisions.

The battle for control of Symbion Health has taken another twist with Sigma Pharmaceuticals launching a billion dollar bid. Skip to main content. ABC News ... Symbion future uncertain after new offer.

Australia's Symbion Health Ltd. <SYB.AX> said on Tuesday that Sigma Pharmaceuticals Ltd. <SIP.AX> offered A$1.085 billion ($912 million) for its consumer and pharmacy businesses, trumping a rival ...

Sigma last Wednesday made a $1.085 billion indicative proposal, in conjunction with Carnegie, Wylie & Co and Sun Super, to buy part of Symbion's business, but Symbion dismissed it as incomplete.

Australian drugs company Sigma Pharmaceuticals Ltd. <SIP.AX> said on Wednesday it would decide whether to launch a rival offer for takeover target Symbion Health <SYB.AX> in the next two weeks.

Add articles to your saved list and come back to them any time. SYMBION Health wants to make rival Sigma Pharmaceuticals pay a high price for pharmacy wholesaler Australian Pharmaceutical ...

TAKEOVER target Symbion Health has rebuffed the attempt of Sigma Pharmaceuticals to muscle in with a higher, but incomplete, $1.08 billion offer for its pharmacy and consumer products business.

Australia’s Sigma Pharmaceuticals on Thursday emerged as a potential bidder for the pharmacy services and consumer businesses of domestic rival Symbion Health, potentially creating an obstacle ...

TAKEOVER target Symbion Health has rebuffed Sigma Pharmaceuticals' attempt to muscle in with a higher but incomplete $1.08 billion offer for its pharmacy and consumer products business.

Symbion Health says it has received a "superior" bid from Sigma Pharmaceuticals and is now recommending the offer over an earlier one from hospital operator Healthscope.